References
- Garey KW, Rege M, Pai MP et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43(1), 25–31 (2006).
- León C, Ruiz-Santana S, Saavedra P et al.; EPCAN Study Group. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit. Care Med. 34(3), 730–737 (2006).
- Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann. Intensive Care 1, 37 (2011).
- Tissot F, Hauser PM, Eggimann P et al. Monitoring of 1,3-𝛃-d-glucan in high-risk surgical ICU patients for early diagnosis of invasive candidiasis: a prospective study of the Fungal Infection Network of Switzerland (FUNGINOS). Presented at: The 50th Interscience Conference for Antimicrobial Agents and Chemotherapy. Boston, MA, USA, 12–15 September 2010 (Abstract M-1071).
- Posteraro B, De Pascale G, Tumbarello M et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-𝛃-d-glucan assay, Candida score, and colonization index. Crit. Care 15(5), R249 (2011).
- Nguyen MH, Wissel MC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, 𝛃-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin. Infect. Dis. 54(9), 1240–1248 (2012).
- Morrissey CO, Chen SC, Sorrell TC et al. Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies. Leuk. Lymphoma 52(2), 179–193 (2011).
- De Pauw B, Walsh TJ, Donnelly JP et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46(12), 1813–1821 (2008).
- White PL, Mengoli C, Bretagne S et al.; European Aspergillus PCR Initiative (EAPCRI). Evaluation of Aspergillus PCR protocols for testing serum specimens. J. Clin. Microbiol. 49(11), 3842–3848 (2011).
- Torelli R, Sanguinetti M, Moody A et al. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J. Clin. Microbiol. 49(12), 4273–4278 (2011).
- Morrissey O, Chen S, Slavin M. Randomized controlled trial of two diagnostic strategies for invasive aspergillosis (IA) in high-risk hematology patients. Presented at: The 51st Interscience Conference for Antimicrobial Agents and Chemotherapy. Chicago, IL, USA, 17–20 September 2011 (Abstract M-1136).
- Sung L, Phillips R, Lehrnbecher T. Time for paediatric febrile neutropenia guidelines – children are not little adults. Eur. J. Cancer 47(6), 811–813 (2011).
- Phillips B, Wade R, Stewart LA, Sutton AJ. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. Eur. J. Cancer 46(16), 2950–2964 (2010).
- Vedi A, Cohn R. Oral versus intravenous antibiotic therapy in treatment of paediatric febrile neutropenia.J. Paed. Child Health doi:10.1111/j.1440-1754.2011.02201.x (2011) (Epub ahead of print).
- Teuffel O, Ethier MC, Alibhai SM, Beyene J, Sung L. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann. Oncol. 22(11), 2358–2365 (2011).
- Teuffel O, Sung L. Advances in management of low-risk febrile neutropenia. Curr. Opin. Pediatr. 24(1), 40–45 (2012).
- Macher E, Dubos F, Garnier N et al. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr. Blood Cancer 55(4), 662–667 (2010).
- Phillips RS, Sutton AJ, Riley RD, Chisholm JC, Picton SV, Stewart LA; the PICNICC Collaboration. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst. Rev. 1(1), 8 (2012).
- Deasy A, Read RC. Genetic variation in pro-inflammatory cytokines and meningococcal sepsis. Curr. Opin. Infect. Dis. 23(3), 255–258 (2010).
- Brouwer MC, Read RC, van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 10(4), 262–274 (2010).